<div id="readability-page-1"><div>Humana Inc., a leading health and well-being company, has released its 2025 Form 10-K report, detailing significant financial and operational achievements, strategic initiatives, and the challenges it faces in the competitive healthcare industry. The report underscores Humana's commitment to enhancing healthcare delivery through its integrated care model and strategic focus on Medicare and Medicaid services. Financial Highlights Total Revenues: $129,664 million, reflecting a 10.1% increase from the previous year primarily due to higher per member Medicare premiums and membership growth in state-based contracts and stand-alone PDP businesses.Income from Operations: $2,704 million, a 5.5% increase from the previous year, driven by increased revenues and administrative cost efficiencies.Net Income: $1,203 million, a slight decrease of 0.9% from the previous year, impacted by put/call valuation adjustments, charges associated with value creation initiatives, and impairment charges.Diluted Earnings Per Common Share: $9.84, a decrease of 1.4% from the previous year, influenced by similar factors affecting net income.Operating Expenses: $126,960 million, a 10.2% increase from the previous year, primarily due to higher benefits and operating costs. Business Highlights Business Segments: Humana operates through two main segments: Insurance and CenterWell. The Insurance segment includes Medicare benefits, Medicaid, dual eligible demonstration, Long-Term Support Services, specialty health insurance benefits, military services, and the PBM business. The CenterWell segment focuses on pharmacy solutions, primary care, and home solutions, enhancing the overall healthcare experience.Revenue Segments: The Insurance segment's premiums and services revenue for 2025 was $123.8 billion, with significant contributions from Individual Medicare Advantage ($90.4 billion), Group Medicare Advantage ($9.0 billion), and Medicare stand-alone PDP ($6.8 billion). The CenterWell segment reported $22.5 billion in total revenues, with pharmacy solutions contributing $11.7 billion in intersegment revenues.Geographical Performance: Florida remains a key market for Humana, with 1.0 million individual Medicare Advantage members and $17.8 billion in premiums revenue, representing 20% of individual Medicare Advantage premiums revenue.Sales Units: Total insurance medical membership at the end of 2025 was approximately 15 million, with significant membership in Individual Medicare Advantage (5.2 million) and Military services (4.6 million).New Product Launches: Humana continues to expand its Medicare Advantage offerings, including Dual-Eligible Special Needs Plans (D-SNP) and stand-alone prescription drug plans (PDPs), with a focus on integrating Medicare and Medicaid benefits.Future Outlook: For 2026, Humana anticipates net membership growth in individual Medicare Advantage offerings by approximately 25%, group Medicare Advantage by 150,000 members, and Medicare stand-alone PDP by 1,000,000 members. The company also expects growth in state-based contracts by 25,000 to 100,000 members.Operational Strategy: Humana's integrated care delivery model focuses on quality care, high member engagement, and data analytics. The company is transitioning providers from fee-for-service to value-based arrangements, with 68% of individual Medicare Advantage members in value-based relationships as of December 31, 2025.Operational Highlights: The CenterWell segment saw a 39% increase in services revenue, driven by growth in primary care and pharmacy solutions. The Insurance segment maintained a stable benefit ratio of 90.4% despite changes in business mix and membership.Regulatory Environment: Humana is adapting to regulatory changes, including the Inflation Reduction Act's impact on Medicare Part D, which eliminated the coverage gap and altered cost-sharing dynamics.Human Capital Management: Humana emphasizes a strong and diverse workforce, with a voluntary turnover rate of 13.8% in 2025. The company offers comprehensive benefits and development opportunities to support associate engagement and retention. Strategic Initiatives Strategic Initiatives: In 2025, Humana finalized its exit from the Employer Group Commercial Medical Products business to focus on long-term strategic plans. The company initiated a multi-year transformation program to realign its cost structure, operating model, and technology footprint in response to macroeconomic, regulatory, and competitive pressures. This included value creation initiatives aimed at cost savings and productivity improvements, resulting in charges of $449 million in 2025.Capital Management: Humana engaged in several capital management activities, including issuing $1.5 billion in senior notes in March 2025 and repurchasing $200 million of senior notes under a Rule 10b5-1 Repurchase Plan. The company also repurchased $151 million of its common stock and paid $430 million in dividends to shareholders in 2025. Additionally, Humana maintained significant levels of aggregate excess statutory capital and surplus in its state-regulated operating subsidiaries, with cash, cash equivalents, and short-term investments at the parent company totaling $1.5 billion at the end of 2025.Future Outlook: Humana plans to continue its strategic focus on Medicare and Medicaid services, with anticipated membership growth in individual Medicare Advantage and state-based contracts in 2026. The company intends to leverage its integrated care delivery model to drive long-term growth in membership and earnings. Humana also aims to maintain its investment-grade credit rating and ensure adequate liquidity to fund ongoing operations, regulatory requirements, and future expansion opportunities. Challenges and Risks Challenges and Risks: Humana operates in a highly competitive industry with significant reliance on government contracts, particularly Medicare and Medicaid, which account for a substantial portion of its revenue. The company faces challenges in maintaining and expanding its market share due to intense competition and the potential for new entrants, especially in the Medicare and Medicaid markets. Additionally, the company's business strategy heavily depends on the successful implementation of its integrated care delivery model and expansion of its Medicare programs.Pricing and Cost Management Risks: The company must accurately design and price its products to cover healthcare costs. Failure to do so could materially affect profitability. Factors such as medical cost inflation, increased use of medical services, and changes in government-mandated benefits can lead to higher-than-expected costs.Regulatory and Legislative Risks: Changes in government policies, particularly those affecting Medicare Advantage and Prescription Drug Plans, could impact revenue and profitability. The company is also subject to extensive regulations, including those related to data privacy and security, which could result in significant compliance costs.Operational Risks: The company relies on effective information systems and data integrity. Any failure in these systems, including those incorporating AI/ML technologies, could disrupt operations and lead to financial losses.Cybersecurity Risks: Humana is vulnerable to cybersecurity attacks, which could result in data breaches, regulatory fines, and reputational damage.Legal and Compliance Risks: The company is involved in various legal proceedings, including a lawsuit challenging the 2025 Medicare Advantage Star Ratings. Unfavorable outcomes could result in substantial financial penalties and affect business practices.Market Risks: The company is exposed to market risks, including changes in interest rates and investment portfolio valuations, which could affect financial performance.Management Strategies: Management acknowledges the challenges posed by the competitive landscape and regulatory environment. The company is focused on enhancing its Medicare offerings and expanding its CenterWell segment to mitigate risks associated with government contracts. Additionally, Humana is investing in technology and data analytics to improve operational efficiency and customer experience.SEC Filing: HUMANA INC [ HUM ] - 10-K - Feb. 19, 2026</div></div>

Humana Inc. has released its 2025 Form 10-K report, highlighting a 10.1% increase in total revenues to $129.7 billion, driven by Medicare premium growth. Net income slightly decreased by 0.9% to $1.2 billion. The company operates through Insurance and CenterWell segments, with significant contributions from Medicare Advantage. Humana anticipates membership growth in 2026 and is focusing on an integrated care model. Strategic initiatives include exiting the Employer Group Commercial Medical Products business and a multi-year transformation program. Humana also engaged in capital management activities, maintaining strong liquidity and capital levels.

TradingView

Health Care Select Sector SPDR

HUMANA INC SEC 10-K Report